Texas Node

The Texas Node joined the Clinical Trials Network in September 2005. UT Southwestern faculty collaborate with CTPs representing over 11,000 annual inpatient and outpatient admissions for a primary substance use disorder, with large populations of Hispanic/Latino, African-American, adolescent, and female patients. The CTPs and associated sites also offer specialized treatment and outreach programs for HIV+ patients.

Protocol Involvement

• CTN-0028: Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders
• CTN-0030-A-1: Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
• CTN-0030: Prescription Opiate Abuse Treatment Study (POATS)
• CTN-0031: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
• CTN-0036-Ot: Epidemiology and Ethnographic Survey of “Cheese” Heroin Use among Hispanics in Dallas County
• CTN-0037: Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
• CTN-0044: Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
• CTN-0046: Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
• CTN-0048: Cocaine Use Reduction with Buprenorphine (CURB)
• CTN-0049-A-2: Utilization of the Electronic Medical Record to Assess and Predict 30-Day Readmission Risk Among HIV-Infected Inpatients Enrolled in CTN-0049
• CTN-0049: Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
• CTN-0052: A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
• CTN-0053: Achieving Cannabis Cessation — Evaluating N-Acetylcysteine Treatment (ACCENT)
• CTN-0054: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) for Methamphetamine Use Disorder
• CTN-0064: Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users
• CTN-0068: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
• CTN-0074: Primary Care Opioid Use Disorder (PROUD) Treatment Trial
• CTN-0048-A-1: Pharmacogenetics of Buprenorphine/Naltrexone for Cocaine Dependence in the CURB Study